Skip to main content

Table 2 Clinical characteristics of the 34 Taiwanese patients with MPS II who died between 1995 and 2012

From: Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995–2012

Clinical characteristics

Number (%)

Age at onset of symptoms (years) (n = 32)

2.5 ± 2.1

Age at diagnosis (years) (n = 32)

4.8 ± 3.1

Gestational age (weeks) (n = 24)

39.2 ± 1.8

Birth weight (gram) (n = 24)

3522 ± 581

Birth weight (SDS) (n = 24)

0.56 ± 1.30

Primary cause of death, n (%)

Respiratory failure

19 (56 %)

Cardiac failure

6 (18 %)

Post-traumatic organ failure

1 (3 %)

Infection (sepsis)

1 (3 %)

Unknown

7 (21 %)

Age at death (years)

14.2 ± 4.2

Age at death, n (%)

<5 years

0

5 to <10 years

5 (15 %)

10 to <15 years

16 (47 %)

15 to <20 years

11 (32 %)

20 years

2 (6 %)

Year of death, n (%)

1995–2000

4 (12 %)

2001–2004

10 (29 %)

2005–2008

10 (29 %)

2009–2012

10 (29 %)

Phenotype, n (%)

Severe

31 (91 %)

Intermediate

1 (3 %)

Mild

2 (6 %)

ERT, n (%)

Yes

2 (6 %)

No

32 (94 %)

HSCT, n (%)

 

Yes

2 (6 %)

No

32 (94 %)

  1. MPS mucopolysaccharidosis, SDS standard deviation score, ERT enzyme replacement therapy, HSCT hematopoietic stem cell transplantation